Navigation Links
S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
Date:1/20/2009

SINGAPORE and SAN DIEGO, Jan. 21 /PRNewswire/ -- S*BIO Pte Ltd and Tragara Pharmaceuticals Inc. today announced that S*BIO has granted a worldwide exclusive license to Tragara to develop and commercialize its novel multi-kinase inhibitor SB1317.

Under the terms of the agreement S*BIO is eligible to receive up to US$112.5 million in payments. This includes an upfront fee, development and sales milestone payments and up to double-digit royalties. Additionally, S*BIO will perform certain preclinical activities for Tragara under a defined workplan in return for research fees. Tragara is responsible for all IND enabling, development and commercialization activities under the agreement.

SB1317 is a novel orally-available, multi-kinase inhibitor with excellent pharmacological and pharmaceutical properties. SB1317 development will be initially focused on the treatment of hematologic malignancies and Tragara will also explore the therapeutic potential of the compound's activity in solid tumors.

"Our entire Tragara team is excited about adding SB1317 to our product pipeline," said Thomas M. Estok, President and CEO of Tragara. "S*BIO successfully identified a promising compound for the treatment of hematological and potentially solid tumors and we look forward to further profiling the compound and moving it toward clinical development."

"We are pleased to work with Tragara in rapidly advancing SB1317 through IND enabling studies to the clinic. We chose Tragara as a partner due to a combination of their experience, exciting clinical development plans and commitment to speed. Together we will determine the full breadth of the compound's competitive advantages in a series of preclinical profiling studies prior to Tragara advancing this product through parallel tracks of clinical development," said Dr. Jan-Anders Karlsson, CEO of S*BIO.

About Tragara Pharmaceuticals Inc


'/>"/>
SOURCE S*BIO Pte Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
2. S*BIO Completes US$26 Million Equity Financing
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... promises ultra-fast communication, computation an...ion. But trying to use quantum states as carriers ...Now two physicists have shown, mathematically, how...munication, while keeping the information intact. ...ysical Review Letters and highlighted with a View...
(Date:11/23/2009)...h.,Nov.23/PRNewswire-FirstCall/--NeogenCorporation...Ph.D.,waselectedtoNeogen,sBoardofDirectorsatthecom...wderhasmorethan40yearsofexperienceinthefood,agricu...nctprofessorofagriculturaleconomicsatVirginiaTechU...itedStateschiefagriculturenegotiatorwiththerankofa...
(Date:11/23/2009)...W,Calif.,Nov.23/PRNewswire/--Frost&Sullivan,th...esfordemonstratingleadershipandinnovationThursday,...onAwardsBanquetheldinSanAntonio,Texas. ,, (Logo...OGO ) ,, TheHealthcareInnovationAwardsaregivent...edeliveryandmanagementofhealthcare.Suchcompaniesha...
(Date:11/20/2009)...merican countries have an opportunity to take the ...rs from the University of Valencia (UV), working t...the productive fabric of the Spanish biotechnology...nd plant sectors have more clout than those in Eng...ied to food and plants has been overlooked by the ...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Spanish biotechnology should focus on food and plant sectors to be more competitive 2
...iji Igarashi , Tochigi Cancer Center, To... , Denaturing gradient gel electrophore... used mutation scanning methods. It has evolved...widely used particularly in gene diagnostic labora...c has been reported recently. 1 The more , ...
... Chen,* Michael B. Kimmey,** Teresa A. Brentnall**... and , **Medicine, Division of Gastroent... Washington. , , Introduc...leading cause of cancer death in the U.S. , ...gnosis, 9699% of , patients are incurable...
...ment of Cell and Molecular Biology, Northwestern,...hicago, Il 60611-3008,j-irwin@nwu.edu; Cristin O...ent of Biology, 1600 Holloway Avenue, San Francisc...sfsu.edu , , Introduction ,...gel electrophoresis (DGGE) to , the inves...
Other Biology Technology:Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 2Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 3Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE 2Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE 3DGGE Analysis for Non-Invasive Studies of Primate Diet 2DGGE Analysis for Non-Invasive Studies of Primate Diet 3DGGE Analysis for Non-Invasive Studies of Primate Diet 4
(Date:11/23/2009)...ew studies reveal in unprecedented detail how the ...e new proteins and guide them toward their destina...ar dynamics flexible fitting (MDFF) to examine the...lecular partners. , The first study, in Procee...ns the intimate signaling between the ribosome and...
(Date:11/23/2009)... of General Medical Sciences (NIGMS), part of the ...$42.3 million for grants in scientific areas it id...ped the GO grant program to stimulate biomedical r...e American Recovery and Reinvestment Act (Recovery...se to have a significant impact on a field of biom...
(Date:11/23/2009)...able in German . , A bit of imagination on ...ad thing. It could help to add data from areas whe...t must do so constructively. In order to infer mis... than just imagination, physicists at the Max Plan...eory of spatial perception called information fiel...
Breaking Biology News(10 mins):Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4News from the Latest Issue of Molecular Medicine 57834 1News from the Latest Issue of Molecular Medicine 57834 2Head Lice Meet Their Natural Match Leading Experts Say Safe Solution Proves Best for Lice and Nit Removal 57832 1Head Lice Meet Their Natural Match Leading Experts Say Safe Solution Proves Best for Lice and Nit Removal 57832 21 Swine Flu Shot Enough for Older Kids 57830 11 Swine Flu Shot Enough for Older Kids 57830 21 Swine Flu Shot Enough for Older Kids 57830 3
... Kount Inc.,( http://www.kount.com ), a leading pr...oday announced that the company has received a US ... Kount officials say patent number 7,330,871 "Onli... describes a method for identifying a,customer com...hant website., "An important step in combating fr...
...suance Workstations to Support MS Expanded Driver,...MFORD, Conn., Sept. 25 L-1 Identity,Solutions, In...lutions and,services, today announced that the L-1...d a half year, $5.9 million contract expansion fro...s for 51 complete new driver,s,license issuance wo...
...re-prone communities surrounded by the San Bernard...eir homes from wildland fires, according to a U.S....e Experience of Community Residents in a Fire-Pron...tional Forest," showed about 94 percent of homeown...scussions in 2007 had taken defensible-space steps...
Other Biology News:Kount Receives Patent for Device Fingerprinting 2L-1 Identity Solutions Receives $5.9 Million Driver's License Contract Expansion from the State of Mississippi 2L-1 Identity Solutions Receives $5.9 Million Driver's License Contract Expansion from the State of Mississippi 3Study reveals homeowner perceptions in fire-prone areas 2
...otein II) is involved in translation initiation. P...ns bind to eIF-4E, the mRNA cap-binding protein, a... in cells. Phosphorylation in the appropriate site.... This allows eIF-4E to bind to eIF-4G (p220), the...
Mouse Anti-HSV-2 Glycoprotein G-2 Monoclonal Antibody, Unconjugated, Clone H1206 from Meridian Life Science, Inc.
...es two unrelated proteins both of which function i...le in a p53-dependent manner. p14^ARF^ binds to md...einrequired for mdm2 modification and concurrent p...on is mediated by the exon 1Beta-encoded N-termina...
...ins a precipitant to ensure that the samples sink ...r to follow the progress of electrophoresis. Com...tary mixture of red dye and precipitant with the ...ecular weight markers. It is the same dye used in ...
Biology Products: